We are proud to inform you about two SAKK trials presented during the 2020 Genitourinary Cancers Symposium, February 13-15, San Francisco, United States.

The abstracts listed below have been accepted for Poster display sessions:

• Alexandros Papachristofilou et al.: Treatment compliance and early toxicity in SAKK 01/10: Single-dose carboplatin and involved-node radiotherapy for treatment of stage IIA/B seminoma.

Further information: https://meetinglibrary.asco.org/record/183223/abstract

• Richard Cathomas et al.: Perioperative chemoimmunotherapy with durvalumab (Durva) in combination with cisplatin/gemcitabine (Cis/Gem) for operable muscle-invasive urothelial carcinoma (MIUC): Preplanned interim analysis of a single-arm phase II trial (SAKK 06/17). 

Further information: https://meetinglibrary.asco.org/record/184042/abstract

Further information can be found on the ASCO website.